Home › Stocks › GRDN › All Fund Holders
GRDN — GUARDIAN PHARMACY SVCS INC · All Fund Holders
Funds holding (latest): 36 · Reported value held: $470.05M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.24M | $135.73M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 1.73M | $72.39M | 0.01% | Reduce |
| BlackRock Inc history | Q2 2026 | 1.58M | $65.99M | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 1.35M | $40.73M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 966.21K | $40.46M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 646.70K | $27.08M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 312.00K | $13.06M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 211.38K | $8.85M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 171.69K | $7.19M | 0.00% | Add |
| Lazard Asset Management history | Q2 2026 | 169.53K | $7.10M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 163.17K | $6.83M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 120.61K | $5.05M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 98.21K | $4.11M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 97.97K | $4.10M | 0.00% | Reduce |
| Royce & Associates history | Q2 2026 | 87.10K | $3.65M | 0.03% | Hold |
| Invesco Ltd history | Q2 2026 | 73.87K | $3.09M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 73.84K | $3.09M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 72.52K | $3.04M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 71.62K | $3.00M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 60.12K | $2.52M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 44.80K | $1.88M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 42.98K | $1.74M | 0.00% | New |
| Marshall Wace history | Q2 2026 | 36.00K | $1.51M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 32.72K | $1.37M | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 27.00K | $1.13M | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 25.77K | $1.08M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 24.37K | $1.02M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 15.52K | $649.61K | 0.00% | Add |
| Balyasny Asset Management history | Q4 2025 | 19.03K | $572.70K | 0.00% | New |
| Manulife Financial history | Q2 2026 | 12.13K | $507.97K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 11.73K | $491.30K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 13.00K | $490.04K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 7.30K | $305.65K | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 6.19K | $259.13K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 89 | $3.73K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 14.32K | $600 | 0.00% | Reduce |